The outlook of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key markets has introduced considerable risk . Investors are now assessing the impact of rival medications , d